Back to All Events

Targeting huntingtin as a therapeutic strategy for Huntington’s disease

Stanford & Northwestern Proteostasis Consortium Weekly Seminar:

Come listen to Dr. GILLIAN BATES (UCL QUEEN SQUARE INSTITUTE OF NEUROLOGY) talk about ‘Targeting huntingtin as a therapeutic strategy for Huntington’s disease’.

Registration is free! Sign up to get the link here.

Previous
January 26

Beyond just targeting: Ubiquitin modulates the conformational changes and substrate degradation of the 26S proteasome
Next
February 9

Solution NMR Reveals the Critical Role of Dynamics in Driving the Function of Molecular Machines